Riverbridge Partners LLC Glaukos Corp Transaction History

Riverbridge Partners LLC

  • $7.1 Billion
  • Q2 2024

A detailed history of Riverbridge Partners LLC transactions in Glaukos Corp stock. As of the latest transaction made, Riverbridge Partners LLC holds 493,075 shares of GKOS stock, worth $63.8 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
493,075
Previous 534,514 7.75%
Holding current value
$63.8 Million
Previous $50.4 Million 15.79%
% of portfolio
0.82%
Previous 0.64%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024
SELL
$89.48 - $118.35 $3.71 Million - $4.9 Million
-41,439 Reduced 7.75%
493,075 $58.4 Million
Q1 2024

Apr 26, 2024
SELL
$76.4 - $96.33 $1.04 Million - $1.31 Million
-13,622 Reduced 2.49%
534,514 $50.4 Million
Q4 2023

Feb 15, 2024
SELL
$59.53 - $85.11 $616,195 - $880,973
-10,351 Reduced 1.85%
548,136 $43.6 Million
Q4 2023

Jan 24, 2024
SELL
$59.53 - $85.11 $607,801 - $868,973
-10,210 Reduced 1.85%
541,078 $43 Million
Q3 2023

Feb 15, 2024
BUY
$69.23 - $79.09 $1.21 Million - $1.38 Million
17,409 Added 3.22%
558,487 $42 Million
Q3 2023

Oct 16, 2023
SELL
$69.23 - $79.09 $1.18 Million - $1.35 Million
-17,076 Reduced 3.0%
551,288 $41.5 Million
Q2 2023

Jul 25, 2023
SELL
$45.44 - $71.21 $524,695 - $822,261
-11,547 Reduced 1.99%
568,364 $40.5 Million
Q1 2023

Apr 21, 2023
SELL
$43.88 - $52.48 $828,673 - $991,084
-18,885 Reduced 3.15%
579,911 $29.1 Million
Q4 2022

Jan 11, 2023
SELL
$40.82 - $57.75 $525,108 - $742,896
-12,864 Reduced 2.1%
598,796 $26.2 Million
Q3 2022

Oct 26, 2022
SELL
$46.84 - $58.49 $101,549 - $126,806
-2,168 Reduced 0.35%
611,660 $32.6 Million
Q2 2022

Aug 29, 2022
SELL
$34.86 - $63.77 $981,169 - $1.79 Million
-28,146 Reduced 4.38%
613,828 $27.9 Million
Q2 2022

Jul 11, 2022
BUY
$34.86 - $63.77 $297,111 - $543,511
8,523 Added 1.35%
641,974 $29.2 Million
Q1 2022

Apr 20, 2022
BUY
$44.33 - $57.82 $3.5 Million - $4.56 Million
78,896 Added 14.23%
633,451 $36.6 Million
Q4 2021

Jan 14, 2022
BUY
$40.27 - $56.99 $327,153 - $462,986
8,124 Added 1.49%
554,555 $24.6 Million
Q3 2021

Oct 26, 2021
SELL
$47.43 - $84.23 $58,196 - $103,350
-1,227 Reduced 0.22%
546,431 $26.3 Million
Q2 2021

Jul 26, 2021
BUY
$73.06 - $97.7 $40 Million - $53.5 Million
547,658 New
547,658 $46.5 Million

Others Institutions Holding GKOS

# of Institutions
303
Shares Held
47M
Call Options Held
75.3K
Put Options Held
157K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.16B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Riverbridge Partners LLC Portfolio

Follow Riverbridge Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email